Elevance Health files 8-K for third-quarter results and financial data
Elevance Health filed an 8-K reporting third-quarter results and financial information for the period ended Oct. 21, 2026. The filing makes the earnings release an immediate test of whether its large revenue base is translating into improved profitability.
STOCK PHOTO · PHIL EVENDENThe story
Elevance Health filed a Form 8-K with the SEC on Oct. 21 under Item 2.02, Results of Operations and Financial Condition, and Item 9.01, Financial Statements and Exhibits. The filing includes an earnings-release exhibit identified as “a3q2026elvearningsrelease.htm,” covering the company’s third-quarter results.
The filing was accepted at 06:01:36 UTC and lists Oct. 21 as the period of report. The submission contains 18 documents, including the 8-K, the earnings release, graphics and XBRL files.
Elevance Health operates in hospital and medical service plans and trades under ELV. Its FY2025 revenue was $199.1B, up 12.5% year over year, while net margin was 2.8% and diluted EPS was $25.21.
The filing index establishes that results were reported, but the detailed financial figures and outlook are not included in the filing-index text. The next read depends on the earnings release’s quarterly revenue, medical cost trends, earnings and guidance details.
Management commentary and the company’s next quarterly disclosures should clarify whether the third-quarter figures alter the profitability trajectory implied by the prior-year figures.
Our read · Wed, Oct 21
Elevance Health (ELV) filed an 8-K covering third-quarter results and financial information with the SEC.
Why. The filing creates a fresh earnings checkpoint, but the available filing detail does not establish whether revenue, medical costs or guidance changed the profit outlook. ELV’s $199.1B FY2025 revenue base and 2.8% net margin make the quarterly margin and earnings figures more consequential than the filing label alone.
Both cases
What could change this view: The trade read fails if the detailed earnings release shows a clearly quantified change in earnings, medical-cost trends or guidance that is not captured in the filing index.
Who reported it · 1
Keep reading
Latest on the Wire
Taiwan readies $15BN fund as Seoul waives margin calls after AI selloffSMCI files 10-Q — Quarterly Report: 10-QHims ends GLP-1 compounding in Lilly deal as shares rallyUS adds 165,000 jobs in October as wages rise and unemployment fallsTrump weighs renewed Iran strikes as negotiators review a new proposalContinue on the Wire →Latest on the Wire
Trump weighs renewed Iran strikes as negotiators review a new proposalBitcoin holds $76,000 as Nasdaq futures rebound 1.5% before jobs dataFed holds rates as stable labor market keeps December hike on trackTesla to wind down Cybertruck production as Musk pivots to roboticsContinue on the Wire →Top this week
Democrats sweep Congress, setting Trump up for legislative gridlockFutures rebound after blue sweep as dollar slides and gold tops $4,000Bitcoin plunges as AI chip selling drags Nasdaq down more than 2%Trump’s Republican Party faces a midterm verdict from US voters todayBitcoin faces renewed pressure as Binance hack intensifies market fearAbout this report
Reported by SEC EDGAR as ELV files 8-K — Elevance Health, Inc.
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →